This is My Australia looks at the inspiring stories of recipient and nominees of the Australian Of The Year Awards. Channel 10, Friday Jan 17th at 7:30PM AFL great and community leader Adam Goodes is one of eight finalists for the prestigious Australian of the Year Award 2014. An
Andyamathanha man, Adam is a professional Australian Rules football
player with the Sydney Swans. He holds an elite place in AFL history,
winning two Brownlow Medals and two premierships. Adam is actively
involved with several Indigenous sport and community programs and as a
leader, speaks out against racism in sport and society. When
asked to identify three Australians that inspire him, Adam named his
mum, Lisa Sansbury, former coach Paul Roos and friend Michael
O'Loughlin.
The Dallas Cowboys will kick off the 124th annual Salvation Army Red Kettle Campaign when the Jones family makes this season’s first official kettle donation at halftime of the nationally televised Cowboys Thanksgiving Day game on FOX against the Philadelphia Eagles. For the past 18 years, the Dallas Cowboys have helped The Salvation Army kick off the campaign, which has raised more than $1.8 billion in that time.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7346053-salvation-army-dallas-cowboys-kick-off-124th-red-kettle-campaign/
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Nearly three in four American voters (74 percent) favor increasing federal funding for cancer research, according to the results of a new national survey conducted on behalf of the American Association for Cancer Research (AACR). The survey results were released today in conjunction with the AACR’s fifth annual Cancer Progress Report. The report highlights how federally funded research can power progress against cancer and urges Congress and the administration to implement a strategy for providing annual budget increases of at least 7 percent for the National Institutes of Health (NIH), National Cancer Institute (NCI), and U.S. Food and Drug Administration (FDA) in fiscal year 2016 and thereafter.
The national survey, which was conducted by Hart Research Associates and Public Opinion Strategies, shows that five out of every six voters recognize what the AACR Cancer Progress Report 2015 details: that progress is being made against cancer.
To view the multimedia release go to:
http://www.multivu.com/players/English/7613551-aacr-cancer-research-survey/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
A fast paced debut novel about a young mans moral struggle in the face of fantastic financial incentives. Set against the stunning mountainous backdrop of La Paz and interspersed with Bolivias sad history of stubborn survival, Mountford examines the critical choices a young man makes as his world closes in on him. Learn more about this book here, http://bit.ly/9DlPxt and its author here, http://bit.ly/afUraU Fiction
When a life-changing diagnosis brings moments of uneasiness, a glimmer of hope can make all the difference in bringing solace. As hope comes in many forms, Extended Stay America® hotels, the nation’s largest owner operated hotelier, announced today the launch of the brand’s latest initiative in their continued support for the fight against cancer – the “Give Hope” program. A natural evolution of Extended Stay America’s partnership with the American Cancer Society, the “Give Hope” program provides a platform to raise awareness and funds for pediatric cancer research.
To view the multimedia release go to:
https://www.multivu.com/players/English/8060751-extended-stay-america-give-hope-cancer-research/
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
Al-Mujahedeen Army
This Video Shows 50 IED Attacks Against The U.S Occupation Forces In My Beloved Country Iraq The Attacks Shown In This Video Executed By Al-Mujahedeen Army Fighters
Power and construction partners Westinghouse and CB&I joined community leaders and project workers at a special event to mark a year of progress at the historic expansion of Plant Vogtle near Waynesboro, Ga. Against the backdrop of the nearly complete 600 foot-tall Unit 3 cooling tower, attendees came together to commemorate the efforts of the more than 5,000 workers currently onsite building two of the country’s first new nuclear units in three decades.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7398151-georgia-power-plant-vogtle-expansion-marks-year-of-progress/
The 10th annual Avon Foundation for Women Gala tonight honored exceptional women and men for their efforts to end breast cancer and violence against women. The event, held at Cipriani 42nd Street in New York City, has raised more than $20 million for Avon philanthropy in the decade since it launched. The event was hosted by Reese Witherspoon, award-winning actress and Honorary Chair of the Avon Foundation for Women, and Andrea Jung, Chairman and CEO, Avon Products, Inc., with a special musical performance by Melissa Etheridge.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/avon/42979/
